# Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-19 21:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Intelligence Brief
"Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by Barron's, Fierce Biotech, Yahoo Finance and Reuters. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Da?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Germany, Merck, Silence, Agreement, Enters, Therapeutics, Acquired, KGaA, Darmstadt

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Barron's | Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125% | 2026-10-19 12:00 | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxOM25STHJOVlAtRVlFVDF3anNYSGVMV3lOdVJhYTlocFQ3VjJ4S2MtZkx6dXRyVU50QzJycUpzWDhtUWVGWDhoTFU0OTliM1lUZFkxZE5EUjBIQTNYSEQtZlN5dWUzU2RzdnRqSlRKTkdMY19Yd3duRjZfcmxxVTF4U0dGUkZRaXg3SDBB?oc=5) |
| Fierce Biotech | Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win | 2026-10-19 12:00 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxPS0thWVhNT25kSnpmLW9LTVhVYmR0Szdfek53QUJkVjZJeW1sU0dnSVZ4cnVfeGdjeHNnY0dCSkpudHlIMEpCb0E4WDJ6Z2RYaHBRZmtocmZuUkUxWnpJQ2E5Zjljc2FnZ3FZeVh0eWJyblFDTzJfSjZDZ0JnSWxKYWhnMHFRVHFIbHBQaGxFVUFYOWUtTDNxdHJiNklKWWsyMDlTbjln?oc=5) |
| Yahoo Finance | Silence Therapeutics stock soars 125% on Merck acquisition | 2026-10-19 12:00 | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxPc2wyaGdHbFdPYy1oNzFkQ0hZUE9ESHlubm9lemNCQ05Dd2FtNTN0UWFkVjVDNkY0SDdTa0ZIUEFFTU1QSWlZYXRJOC1icEhmNHpQNEJUakZ0N2o3OHBUMW05WlQ2MmpoRHhtZW9ScS1rNkhQU2htVThScTdqRkFhZFlpTUdSck8xUzNmaFZsNjRnNVZyM2tKT3BLUGNndXNsVVhR?oc=5) |
| Reuters | Germany's Merck buys Silence Therapeutics in $1.3 billion RNA drug deal | 2026-10-19 12:00 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxOcUlEVktsZWQxcVRvT3N3c0FhbXFaSS0xeDhNY2xWSWQzRDgxWHZ5SjhnUkJERjhsRmVlZHJuWnhkdHlKYUNWMWQ1R3E2MEFUaTgwRkNfOGV1alg3cjA2Nk5ielhPWVZfdWlJaXpMT3lDWEJGdU0yWlI2R0VsZVJ3cGNGaHpreHVxSUd4UUtzbWFkQlhrZjBFdHd0N0xEdGo5Rl9QY2k5UQ?oc=5) |
| Business Wire | Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany | 2026-10-19 12:00 | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxQbnpKbnFRUXVoU2lVcXROczZnRzJCX3RhZUxKTmlsbHVBb21Cd1hUb3BvRno4Tk9RWkJIaFdXODBhVndhb3k1ZExZYmltNHVsLWdjTDdnUnRiYms0dmJFb0hIMFVmWUdpTXFNU25wc21UclY1d0RXaHNTN1NHbU5UNml5R3ZfbVJUSDdQNEZZN2JTTnFTOVl2dWZoSmxWMzFhd0RobEw4STktX2VZeWRFb3Q5ZXRSS1diZU1naXVFeDVMenBKR2M1LU40WjdOQ3U3X3hlRVdJeWk1VXhLM0dR?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-19/silence-therapeutics-enters-into-agreement-to-be-acquired-by-merck-kgaa*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*